Facebook tracking pixelNonrheumatic Mitral Valve Regurgitation - AI-Powered ICD-10 Documentation
I34.0
ICD-10-CM
Nonrheumatic Mitral Valve Regurgitation

Find information on nonrheumatic mitral valve regurgitation including clinical documentation requirements, ICD-10-CM codes I05.1, I05.8, I34.0, and I34.8, medical coding guidelines, and healthcare resources for diagnosis and treatment. Learn about mitral regurgitation severity, echocardiogram interpretation, and effective clinical care pathways. This resource offers guidance on proper documentation and coding for nonrheumatic mitral valve regurgitation for physicians, coders, and other healthcare professionals.

Also known as

Mitral Insufficiency
Mitral Valve Incompetence

Diagnosis Snapshot

Key Facts
  • Definition : Leakage of blood backward through the mitral valve of the heart.
  • Clinical Signs : May be asymptomatic. Shortness of breath, fatigue, heart murmur are possible.
  • Common Settings : Primary care, cardiology clinic, hospital (for severe cases)

Related ICD-10 Code Ranges

Complete code families applicable to AAPC I34.0 Coding
I05-I09

Chronic rheumatic heart diseases

Includes chronic rheumatic mitral valve disorders, often causing regurgitation.

I07

Mitral valve disorders

Encompasses various mitral valve problems, including nonrheumatic regurgitation.

I07.1

Mitral regurgitation

Specifically identifies mitral regurgitation, both rheumatic and nonrheumatic.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the mitral regurgitation acute?

  • Yes

    Is it due to infective endocarditis?

  • No

    Is it caused by a cleft or anomaly?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Mitral regurgitation, nonrheumatic
Mitral valve prolapse
Ischemic mitral regurgitation

Documentation Best Practices

Documentation Checklist
  • Document regurgitation severity (mild, moderate, severe)
  • Specify mitral valve morphology (e.g., prolapse, flail)
  • Etiology of Nonrheumatic MR (degenerative, ischemic, etc.)
  • Symptoms (dyspnea, fatigue, etc.) and impact on daily life
  • Left ventricle size and function assessment (EF, LV dimensions)

Coding and Audit Risks

Common Risks
  • Unspecified Etiology

    Coding I05.1 without specifying underlying cause (e.g., I05.8, I07.1) leads to inaccurate severity and reimbursement. Impacts CDI, coding audits, and quality metrics.

  • Severity Mismatch

    Inconsistent documentation of regurgitation severity (mild, moderate, severe) with echocardiogram findings. Risk for incorrect coding, denials, and compliance issues.

  • Comorbidity Overlap

    Overlapping conditions like mitral valve prolapse (I34.x) and mitral valve regurgitation. Accurate coding requires careful differentiation for appropriate reimbursement and clinical data.

Mitigation Tips

Best Practices
  • Thorough echo assessment: Precise regurgitant jet & LA/LV size for accurate staging.
  • ICD-10-CM I05.1, I05.9: Specify etiology (degenerative, ischemic, etc.) for correct coding.
  • Document supporting symptoms, exam findings, & echo results per CDI guidelines.
  • Correlate echo findings with clinical presentation for consistent diagnosis.
  • Regular follow-up echoes: Monitor progression & guide timely intervention decisions.

Clinical Decision Support

Checklist
  • 1. Auscultate for systolic murmur at apex radiating to axilla. Document quality and timing.
  • 2. Echocardiogram confirms MR. Quantify severity (mild, moderate, severe).
  • 3. Assess LVEF. Document impact on LV size and function.
  • 4. Review prior studies for MR progression. Correlate with symptoms.

Reimbursement and Quality Metrics

Impact Summary
  • Nonrheumatic Mitral Valve Regurgitation reimbursement hinges on accurate coding (ICD-10 I05.1, I34.0) and documentation for optimal payer reimbursement.
  • Quality metrics like 30-day readmission rates, patient-reported outcomes, and procedural complications impact value-based payments for MR.
  • Coding accuracy directly affects hospital reporting on MR prevalence, severity, treatment outcomes, and resource utilization for quality improvement.
  • Appropriate use criteria adherence and evidence-based treatment strategies for MR improve quality scores and reduce healthcare costs.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes for . Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Code I05.1 for mitral regurgitation
  • Specify cause, e.g., I34.0
  • Document jet severity, location
  • Add DCM, LV dysfunction if present
  • Consider Z95.810 for prosthetic valve

Documentation Templates

Patient presents with symptoms suggestive of nonrheumatic mitral valve regurgitation (MR), including dyspnea, fatigue, and orthopnea.  Physical examination revealed a holosystolic murmur at the apex, radiating to the axilla.  The patient denies a history of rheumatic fever.  Echocardiography confirms the diagnosis of moderate mitral regurgitation, with evidence of mitral valve prolapse and annular dilatation.  Left ventricular ejection fraction (LVEF) is currently preserved at 60%.  Differential diagnoses considered include ischemic mitral regurgitation and mitral valve stenosis, but these were ruled out based on echocardiographic findings and lack of angina symptoms.  Assessment includes moderate nonrheumatic mitral regurgitation secondary to mitral valve prolapse, New York Heart Association (NYHA) functional class II.  Plan includes initiating treatment with diuretics to manage fluid overload and symptoms.  Patient education provided regarding lifestyle modifications, including sodium restriction and regular exercise.  Follow-up echocardiography scheduled in six months to monitor disease progression and LVEF.  Referral to cardiology for further evaluation and consideration for mitral valve repair or replacement surgery if symptoms worsen or LVEF declines.  ICD-10 code I05.1, mitral regurgitation, is documented.  Medical necessity for the prescribed medications and diagnostic tests is established.